Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body ContouringBusiness Wire • 04/28/23
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023Business Wire • 04/05/23
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial OutlookBusiness Wire • 03/16/23
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where NeededBusiness Wire • 02/27/23
Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap FinancialBusiness Wire • 02/21/23
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023Business Wire • 02/16/23
RENUVION® COSMETIC NECK LAXITY PROCEDURE TO BE FEATURED ON 'THE BALANCING ACT' TALK SHOW ON LIFETIME® FEBRUARY 13PRNewsWire • 02/09/23
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following LiposuctionBusiness Wire • 02/01/23
APYX MEDICAL CORPORATION LAUNCHES NEW 'APYX ONE CONSOLE' FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATESPRNewsWire • 01/25/23
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue ResultsBusiness Wire • 01/10/23
Apyx Medical Corporation to Participate in the Piper Sandler 34th Annual Healthcare ConferenceBusiness Wire • 11/22/22
Apyx Medical Corporation Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial OutlookBusiness Wire • 11/10/22
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022Business Wire • 09/26/22
'BOTCHED' TV STAR DR. PAUL NASSIF AMONG TOP U.S. PLASTIC SURGEONS USING RENUVION® HELIUM PLASMA TECHNOLOGY IN COSMETIC PROCEDURESPRNewsWire • 09/13/22
Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth ConferenceBusiness Wire • 09/06/22
Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/14/22
Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial OutlookBusiness Wire • 08/11/22
APYX SHAREHOLDER ALERT: Jakubowitz Law Reminds Apyx Shareholders of a Lead Plaintiff Deadline of August 5, 2022PRNewsWire • 08/05/22
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/05/22